156 related articles for article (PubMed ID: 36329839)
21. Inhaled bacteriophage therapy in a porcine model of pneumonia caused by Pseudomonas aeruginosa during mechanical ventilation.
Guillon A; Pardessus J; L'Hostis G; Fevre C; Barc C; Dalloneau E; Jouan Y; Bodier-Montagutelli E; Perez Y; Thorey C; Mereghetti L; Cabrera M; Riou M; Vecellio L; Le Guellec S; Heuzé-Vourc'h N
Br J Pharmacol; 2021 Sep; 178(18):3829-3842. PubMed ID: 33974271
[TBL] [Abstract][Full Text] [Related]
22. Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.
Vinodkumar CS; Kalsurmath S; Neelagund YF
Indian J Pathol Microbiol; 2008; 51(3):360-6. PubMed ID: 18723958
[TBL] [Abstract][Full Text] [Related]
23. Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa.
Maharjan A; Nepal R; Dhungana G; Parajuli A; Regmi M; Upadhyaya E; Mandal D; Shrestha M; Pradhan P; Manandhar KD; Malla R
J Nepal Health Res Counc; 2022 Mar; 19(4):717-724. PubMed ID: 35615828
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa.
Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y
J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of lytic bacteriophages against
Majdani R; Shams Ghahfarokhi E
Iran J Microbiol; 2022 Apr; 14(2):203-213. PubMed ID: 35765555
[TBL] [Abstract][Full Text] [Related]
26. Topically Applied Bacteriophage to Control Multi-Drug Resistant
Fayez MS; Hakim TA; Agwa MM; Abdelmoteleb M; Aly RG; Montaser NN; Abdelsattar AS; Rezk N; El-Shibiny A
Antibiotics (Basel); 2021 Aug; 10(9):. PubMed ID: 34572629
[TBL] [Abstract][Full Text] [Related]
27. Development of a Bacteriophage Cocktail to Constrain the Emergence of Phage-Resistant
Yang Y; Shen W; Zhong Q; Chen Q; He X; Baker JL; Xiong K; Jin X; Wang J; Hu F; Le S
Front Microbiol; 2020; 11():327. PubMed ID: 32194532
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P
BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376
[TBL] [Abstract][Full Text] [Related]
29. Isolation and partial characterization of a virulent bacteriophage IHQ1 specific for Aeromonas punctata from stream water.
Ul Haq I; Chaudhry WN; Andleeb S; Qadri I
Microb Ecol; 2012 May; 63(4):954-63. PubMed ID: 21947462
[TBL] [Abstract][Full Text] [Related]
30. Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014.
Villarroel J; Larsen MV; Kilstrup M; Nielsen M
Viruses; 2017 Nov; 9(11):. PubMed ID: 29099783
[TBL] [Abstract][Full Text] [Related]
31. Phage-resistant
Wannasrichan W; Htoo HH; Suwansaeng R; Pogliano J; Nonejuie P; Chaikeeratisak V
Front Microbiol; 2022; 13():1004733. PubMed ID: 36274728
[No Abstract] [Full Text] [Related]
32. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
[TBL] [Abstract][Full Text] [Related]
33. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
34. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT
Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362
[TBL] [Abstract][Full Text] [Related]
35. Treatment of Wound Infections in a Mouse Model Using Zn
Peng H; Rossetto D; Mansy SS; Jordan MC; Roos KP; Chen IA
ACS Nano; 2022 Mar; 16(3):4756-4774. PubMed ID: 35239330
[TBL] [Abstract][Full Text] [Related]
36. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing.
Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ
J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial efficacy of lytic phages against multidrug-resistant Pseudomonas aeruginosa infections in bacteraemia mice models.
Arumugam SN; Manohar P; Sukumaran S; Sadagopan S; Loh B; Leptihn S; Nachimuthu R
BMC Microbiol; 2022 Aug; 22(1):187. PubMed ID: 35909125
[TBL] [Abstract][Full Text] [Related]
38. Directed in Vitro Evolution of Therapeutic Bacteriophages: The Appelmans Protocol.
Burrowes BH; Molineux IJ; Fralick JA
Viruses; 2019 Mar; 11(3):. PubMed ID: 30862096
[TBL] [Abstract][Full Text] [Related]
39.
Pinto AM; Faustino A; Pastrana LM; Bañobre-López M; Sillankorva S
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356798
[No Abstract] [Full Text] [Related]
40. Isolation, Characterization and
Marashi SMA; Nikkhahi F; Hamedi D; Shahbazi G
Infect Chemother; 2022 Mar; 54(1):153-164. PubMed ID: 35384426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
